DK1414421T3 - Behandling af lipodystrofi med inhibitorer af renin-angiotensinsystemet - Google Patents
Behandling af lipodystrofi med inhibitorer af renin-angiotensinsystemetInfo
- Publication number
- DK1414421T3 DK1414421T3 DK02749123T DK02749123T DK1414421T3 DK 1414421 T3 DK1414421 T3 DK 1414421T3 DK 02749123 T DK02749123 T DK 02749123T DK 02749123 T DK02749123 T DK 02749123T DK 1414421 T3 DK1414421 T3 DK 1414421T3
- Authority
- DK
- Denmark
- Prior art keywords
- lipodystrophy
- renin
- inhibitors
- treatment
- angiotensin system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0119460.4A GB0119460D0 (en) | 2001-08-09 | 2001-08-09 | The use of inhibitors of the renin-angiotensin system |
| PCT/GB2002/003639 WO2003013486A1 (en) | 2001-08-09 | 2002-08-07 | The treatment of lipodystrophy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1414421T3 true DK1414421T3 (da) | 2008-12-08 |
Family
ID=9920113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02749123T DK1414421T3 (da) | 2001-08-09 | 2002-08-07 | Behandling af lipodystrofi med inhibitorer af renin-angiotensinsystemet |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7022693B2 (hu) |
| EP (1) | EP1414421B1 (hu) |
| JP (1) | JP2005527462A (hu) |
| KR (1) | KR20040054665A (hu) |
| CN (1) | CN1541094A (hu) |
| AP (1) | AP1731A (hu) |
| AT (1) | ATE411012T1 (hu) |
| AU (1) | AU2002319535B2 (hu) |
| CA (1) | CA2456549A1 (hu) |
| DE (1) | DE60229398D1 (hu) |
| DK (1) | DK1414421T3 (hu) |
| ES (1) | ES2332884T3 (hu) |
| GB (1) | GB0119460D0 (hu) |
| HU (1) | HUP0401041A3 (hu) |
| MX (1) | MXPA04001174A (hu) |
| NO (1) | NO20040561L (hu) |
| PL (1) | PL367941A1 (hu) |
| WO (1) | WO2003013486A1 (hu) |
| ZA (1) | ZA200400887B (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100028439A1 (en) * | 2005-05-23 | 2010-02-04 | Elan Pharma International Limited | Nanoparticulate stabilized anti-hypertensive compositions |
| US20070066512A1 (en) * | 2005-09-12 | 2007-03-22 | Dominique Verhelle | Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0635263A3 (en) | 1993-06-28 | 1995-09-27 | American Cyanamid Co | Angiotensin II antagonists (AII) as inhibitors of the growth of adipose tissue. |
| HUP0003982A3 (en) * | 1997-10-17 | 2002-01-28 | Eurogene Ltd | The use of inhibitors of the renin-angiotensin system for producing pharmaceutical compositions using for the treatment of hypoxia or impaired metabolic function |
| US7045532B2 (en) * | 1999-04-30 | 2006-05-16 | Millennium Pharmaceuticals, Inc. | ACE-2 modulating compounds and methods of use thereof |
| CN1268331C (zh) * | 1999-08-30 | 2006-08-09 | 萨诺费－阿文蒂斯德国有限公司 | 肾素－血管紧张素系统抑制剂在制备预防心血管疾病的药物中的用途 |
| US20020013334A1 (en) | 2000-06-15 | 2002-01-31 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
-
2001
- 2001-08-09 GB GBGB0119460.4A patent/GB0119460D0/en not_active Ceased
-
2002
- 2002-08-07 WO PCT/GB2002/003639 patent/WO2003013486A1/en active IP Right Grant
- 2002-08-07 DK DK02749123T patent/DK1414421T3/da active
- 2002-08-07 CN CNA028156129A patent/CN1541094A/zh active Pending
- 2002-08-07 AP APAP/P/2004/002980A patent/AP1731A/en active
- 2002-08-07 US US10/485,018 patent/US7022693B2/en not_active Expired - Fee Related
- 2002-08-07 JP JP2003518496A patent/JP2005527462A/ja active Pending
- 2002-08-07 CA CA002456549A patent/CA2456549A1/en not_active Abandoned
- 2002-08-07 MX MXPA04001174A patent/MXPA04001174A/es active IP Right Grant
- 2002-08-07 HU HU0401041A patent/HUP0401041A3/hu unknown
- 2002-08-07 AT AT02749123T patent/ATE411012T1/de not_active IP Right Cessation
- 2002-08-07 ES ES02749123T patent/ES2332884T3/es not_active Expired - Lifetime
- 2002-08-07 PL PL02367941A patent/PL367941A1/xx not_active Application Discontinuation
- 2002-08-07 AU AU2002319535A patent/AU2002319535B2/en not_active Ceased
- 2002-08-07 EP EP02749123A patent/EP1414421B1/en not_active Expired - Lifetime
- 2002-08-07 KR KR10-2004-7001416A patent/KR20040054665A/ko not_active Application Discontinuation
- 2002-08-07 DE DE60229398T patent/DE60229398D1/de not_active Expired - Fee Related
-
2004
- 2004-02-03 ZA ZA200400887A patent/ZA200400887B/en unknown
- 2004-02-06 NO NO20040561A patent/NO20040561L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04001174A (es) | 2005-02-17 |
| CN1541094A (zh) | 2004-10-27 |
| WO2003013486A1 (en) | 2003-02-20 |
| PL367941A1 (en) | 2005-03-07 |
| HUP0401041A3 (en) | 2004-10-28 |
| CA2456549A1 (en) | 2003-02-20 |
| KR20040054665A (ko) | 2004-06-25 |
| NO20040561L (no) | 2004-03-23 |
| US7022693B2 (en) | 2006-04-04 |
| EP1414421A1 (en) | 2004-05-06 |
| ZA200400887B (en) | 2005-02-03 |
| AP2004002980A0 (en) | 2004-03-31 |
| ES2332884T3 (es) | 2010-02-15 |
| JP2005527462A (ja) | 2005-09-15 |
| AU2002319535B2 (en) | 2005-01-06 |
| GB0119460D0 (en) | 2001-10-03 |
| EP1414421B1 (en) | 2008-10-15 |
| AP1731A (en) | 2007-03-30 |
| US20040209941A1 (en) | 2004-10-21 |
| ATE411012T1 (de) | 2008-10-15 |
| DE60229398D1 (de) | 2008-11-27 |
| HUP0401041A2 (hu) | 2004-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1073658T3 (da) | Pyrazolopyrimidinon-cGMP PDE5-inhibitorer til behandling af sexualforstyrrelse | |
| DK2308507T3 (da) | Fremgangsmåder til behandling af præeklampsi | |
| DK1803718T3 (da) | 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter | |
| DK1575597T3 (da) | Anvendelse af rimexolon til behandling af öjentörhed | |
| DK1259512T3 (da) | Pteridinforbindelser til behandling af psoreasis | |
| AR028253A1 (es) | Inhibidores de la glucogeno fosforilasa | |
| DK1292594T3 (da) | Quinazolinderivater til behandling af tumorer | |
| NO20011121D0 (no) | FremgangsmÕte for formasjonsbehandling med deformerbare partikler | |
| PT1370553E (pt) | Inibidores de rhoquinase | |
| FI20060154A (fi) | Neurogeneratiivisten tilojen hoito | |
| DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
| DK1353694T3 (da) | Kombinationer af ezetimibe med aspirin til behandling af vaskulære tilstande | |
| DK1282616T3 (da) | Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter | |
| DK1206436T3 (da) | Retinoider til behandling af emfysem | |
| DK1411926T3 (da) | Integrininhibitorer til behandling af öjensygdomme | |
| DK1516596T3 (da) | Forbedret system til behandling af stress-urinkontinens | |
| DK1345598T3 (da) | Anvendelsen af rosiglitazon til behandling af psykiatriske lidelser | |
| DE60227963D1 (de) | Behandlungssystem | |
| DK3103443T3 (da) | Fremgangsmåde til behandling af primær søvnforstyrrelse | |
| SE0301854L (sv) | Antiigensättningsbehandling | |
| DK1553952T3 (da) | Anvendelse af dihydroimidazoloner til behandling af epilepsi hos hunde | |
| DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
| NO20040497L (no) | Amidinderivater for behandling av amyloidose | |
| DK1414421T3 (da) | Behandling af lipodystrofi med inhibitorer af renin-angiotensinsystemet | |
| DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme |